Davis, California, USA
June 22, 2020

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that it received notice from The Nasdaq Stock Market, LLC ("Nasdaq") on June 19, 2020 indicating that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2)  for continued listing on The Nasdaq Capital Market.

“We are pleased to announce to our shareholders that the Company has regained full compliance with Nasdaq’s continued listing requirements,” said Pam Marrone, Founder and Chief Executive Officer of Marrone Bio Innovations. “With this matter now resolved, our officers and directors will continue to remain focused on driving growth and creating sustainable shareholder value over the long term.”
 

Website: http://marronebioinnovations.com/

Published: June 22, 2020